Resultados de la búsqueda 601-610 of 1048 for Alternative

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies. A Study to Evaluate VSV-hIFNbeta-NIS to Treat ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to find the maximum tolerated dose of iberdomide for patients newly diagnosed with multiple myeloma, and to determine response ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the ...

  6. Oncología (médica) - Ensayos clínicos

    This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

  9. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric ...

  10. Oncología (médica) - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...